Cuma Suleymanoğlu, Fuat Polat, Rıdvan Yurt, İskan Zengin, Veysi Can
{"title":"Electrocardiographic-Based Assessment in Acute Heart Failure with Left Bundle Branch Block: Insights from a Retrospective Cohort.","authors":"Cuma Suleymanoğlu, Fuat Polat, Rıdvan Yurt, İskan Zengin, Veysi Can","doi":"10.1159/000553619","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Left bundle branch block (LBBB) complicates electrocardiographic interpretation in acute heart failure (AHF). This study aimed to evaluate the relationship between electrocardiographic parameters, including QRS duration, QRS morphology, and the Selvester QRS score (SQS), and echocardiographic findings in patients with AHF presenting with LBBB across different heart failure phenotypes.</p><p><strong>Methods: </strong>In this retrospective cohort, 275 patients hospitalized with AHF and LBBB were analyzed. Patients were classified as heart failure with reduced ejection fraction (HFrEF, left ventricular ejection fraction [LVEF] <40%), heart failure with mildly reduced ejection fraction (HFmrEF, LVEF 40-49%), or heart failure with preserved ejection fraction (HFpEF, LVEF ≥50%). Associations between electrocardiographic (ECG) and echocardiographic parameters were evaluated using Spearman correlation and multivariable regression. Discriminatory performance for reduced systolic function was assessed by receiver operating characteristic (ROC) analysis.</p><p><strong>Results: </strong>Mean age was 61.7 ± 13.8 years and 70.5% were male; median LVEF was 40% (IQR: 27-48%). HFrEF was present in 49.8%. Among ECG indices, only SQS correlated significantly with echocardiographic measures: LVEF (r = -0.447), left ventricular end-diastolic diameter (LVEDD, r = 0.346), left ventricular end-systolic diameter (LVESD, r = 0.373), and LV mass index (r = 0.205) (all p < 0.001). In multivariable analysis, SQS (OR = 1.373, 95% CI: 1.255-1.501, p < 0.001) and LV mass index independently predicted HFrEF. The Hosmer-Lemeshow test confirmed adequate calibration (p = 0.49). ROC analysis showed SQS had moderate discriminatory ability (area under the curve [AUC] 0.768, 95% CI: 0.711-0.825), with an optimal cutoff >43 yielding 74.5% sensitivity and 69.6% specificity. QRS duration and morphology demonstrated no meaningful predictive value (AUC ≈ 0.49).</p><p><strong>Conclusion: </strong>In AHF patients with LBBB, SQS outperforms conventional QRS metrics in identifying reduced LV systolic function. An SQS >43 provides moderate diagnostic accuracy and may support early risk stratification when echocardiography is not immediately available.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"1-11"},"PeriodicalIF":1.9000,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000553619","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Left bundle branch block (LBBB) complicates electrocardiographic interpretation in acute heart failure (AHF). This study aimed to evaluate the relationship between electrocardiographic parameters, including QRS duration, QRS morphology, and the Selvester QRS score (SQS), and echocardiographic findings in patients with AHF presenting with LBBB across different heart failure phenotypes.
Methods: In this retrospective cohort, 275 patients hospitalized with AHF and LBBB were analyzed. Patients were classified as heart failure with reduced ejection fraction (HFrEF, left ventricular ejection fraction [LVEF] <40%), heart failure with mildly reduced ejection fraction (HFmrEF, LVEF 40-49%), or heart failure with preserved ejection fraction (HFpEF, LVEF ≥50%). Associations between electrocardiographic (ECG) and echocardiographic parameters were evaluated using Spearman correlation and multivariable regression. Discriminatory performance for reduced systolic function was assessed by receiver operating characteristic (ROC) analysis.
Results: Mean age was 61.7 ± 13.8 years and 70.5% were male; median LVEF was 40% (IQR: 27-48%). HFrEF was present in 49.8%. Among ECG indices, only SQS correlated significantly with echocardiographic measures: LVEF (r = -0.447), left ventricular end-diastolic diameter (LVEDD, r = 0.346), left ventricular end-systolic diameter (LVESD, r = 0.373), and LV mass index (r = 0.205) (all p < 0.001). In multivariable analysis, SQS (OR = 1.373, 95% CI: 1.255-1.501, p < 0.001) and LV mass index independently predicted HFrEF. The Hosmer-Lemeshow test confirmed adequate calibration (p = 0.49). ROC analysis showed SQS had moderate discriminatory ability (area under the curve [AUC] 0.768, 95% CI: 0.711-0.825), with an optimal cutoff >43 yielding 74.5% sensitivity and 69.6% specificity. QRS duration and morphology demonstrated no meaningful predictive value (AUC ≈ 0.49).
Conclusion: In AHF patients with LBBB, SQS outperforms conventional QRS metrics in identifying reduced LV systolic function. An SQS >43 provides moderate diagnostic accuracy and may support early risk stratification when echocardiography is not immediately available.
期刊介绍:
''Cardiology'' features first reports on original clinical, preclinical and fundamental research as well as ''Novel Insights from Clinical Experience'' and topical comprehensive reviews in selected areas of cardiovascular disease. ''Editorial Comments'' provide a critical but positive evaluation of a recent article. Papers not only describe but offer critical appraisals of new developments in non-invasive and invasive diagnostic methods and in pharmacologic, nutritional and mechanical/surgical therapies. Readers are thus kept informed of current strategies in the prevention, recognition and treatment of heart disease. Special sections in a variety of subspecialty areas reinforce the journal''s value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons, clinical physiologists, pharmacologists and professionals in other areas of medicine interested in current activity in cardiovascular diseases.